Global Vascular Access Devices Outlook 2022

Published: Nov, 2016 | Pages: 115 | Publisher: RNCOS
Industry: Healthcare | Report Format: Electronic (PDF)

The growing incidence of chronic diseases, such as cancer, diabetes, and blood pressure, has further propelled the need for hospitalization. A majority of patients who get hospitalized receive some sort of vascular access treatment during their stay. The vascular access devices are intended for various purposes such as providing parenteral nutrition, transfusion of blood product, providing avenue for hemodynamic monitoring, providing avenue for diagnostic testing, and administration of fluids and medications.

According to a new report by RNCOS, "Global Vascular Access Devices Outlook 2022", the global vascular access devices market is anticipated to grow at a CAGR of 6% during the forecasted period (2016-2022). The market growth is expected mainly due to the growing strategic alliances, technological advancements, growing incidences of cancer and renal disorders, increasing awareness about vascular access devices, and rising incidences of obesity.

The report segments the market on the basis of the product type, applications, route of insertion, end-users, and geography with the future forecasts on all prominent segments of the industry till 2022.

Based on product type, peripheral devices are expected to dominate the market. However, the central vascular access devices segment is expected to witness the highest growth in the coming years. In the central vascular access devices, the leading and fastest-growing segment is the Peripherally Inserted Central Catheters (PICCs), which has a wide range of applications and are commonly used for delivering chemotherapy and antibiotics, as well as drawing blood.

In terms of application of the devices, medication administration is most common application observed amongst all the types of vascular access devices; however, hemodialysis monitoring has an increasing usage in patients with renal diseases. Furthermore, in terms of route of administration, intravenous route accounts for the largest share in the vascular access devices market. On the other hand, based on end-user, the hospital segment is expected to account for largest share.

Based on geography, North America is the largest market for vascular access devices market. However, the Asia-Pacific market is expected to witness the highest growth due to rapidly aging population, increasing hospitalization rate, and growing focus of various players in this region.

The later part of the report focuses on competitive analysis of the key market players, in terms of their market share and their product offerings. Major players operating in this market include Smiths Medical, Becton Dickinson, Teleflex Medical, and C.R. Bard, among others. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player's business model, the player's current and historical financials have been analyzed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends, which will likely generate key interest in investors planning to enter industry.

Table of Contents
1. Analyst View

2. Research Methodology

3. Vascular Access Devices - An Introduction

4. Market Dynamics
4.1 Market Drivers
4.1.1 Growing Burden of Kidney Disease
4.1.2 Rising Acceptance of Vascular Access Products in the Market
4.1.3 Increased Life Expectancy and Subsequent Aging of the Global Population
4.1.4 Technological Advancements
4.2 Market Restraints
4.2.1 High Risk of Complications Associated with VADs
4.2.2 Lack of Skilled Professionals
4.3 Market Trends
4.3.1 Increasing Preference for Polyurethane based Catheters
4.3.2 Rise in Strategic Alliances in Vascular Access Devices Market
4.3.3 Increased Application of VAD's in Pediatrics
4.4 Market Opportunities
4.4.1 Growing Opportunities for Coated and Impregnated Antimicrobial Catheters
4.4.2 High Growth Asian Market

5. Vascular Access Devices Market Outlook 2022

6. Vascular Access Devices Market, By Product
6.1 Introduction
6.1.1 Peripheral Vascular Access Devices (PVAD)
6.1.1.1 Peripheral Intravenous Catheters (PIVC)
6.1.1.2 Midline Catheters
6.1.2 Central Vascular Access Devices (CVAD)
6.1.2.1 Peripherally Inserted Central Catheters (PICC)
6.1.2.2 Temporary/Non-Tunneled Central Venous Catheters
6.1.2.3 Permanent/Tunneled Central Venous Catheters
6.1.2.4 Implantable Ports
6.1.3 Accessories

7. Vascular Access Devices Market, By Application
7.1 Introduction
7.1.1 Medication Administration
7.1.2 Diagnostic Testing
7.1.3 Blood & Blood Product Transfusion
7.1.4 Haemodialysis Monitoring
7.1.5 Hemodynamic Monitoring

8. Vascular Access Devices Market, By Insertion Route
8.1 Introduction
8.1.1 Intravenous
8.1.2 Subcutaneous
8.1.3 Intraosseous

9. Vascular Access Devices Market, By End User
9.1 Introduction
9.1.1 Hospitals & Clinics
9.1.2 Ambulatory Surgical Centers
9.1.3 Catheterization Laboratories

10. Vascular Access Devices Market, By Region
10.1 Introduction
10.1.1 North America
10.1.2 Europe
10.1.3 Asia Pacific
10.1.4 Rest of the World (RoW)

11. Company Profiles
11.1 C. R. Bard, Inc.
11.2 AngioDynamics, Inc.
11.3 Smiths Medical
11.4 Fresenius Medical Care
11.5 Teleflex Incorporated
11.6 Medtronic plc
11.7 Becton, Dickinson And Company
11.8 B. Braun Melsungen AG
11.9 NIPRO Medical Corporation
11.10 Medical Components, Inc.

List of Tables:
 
Table 4-1: Global - Mergers & Acquisitions
Table 4-2: Central Venous Catheters Commonly Used in the Pediatric Population
Table 6-1: Global - Vascular Access Devices Market by Product (Billion US$), 2016
Table 6-2: Types of Central Vascular Access Devices
Table 6-3: Types of Accessories
Table 7-1: Global - Vascular Access Devices Market by Application (Billion US$), 2016
Table 8-1: Global - Vascular Access Devices Market by Insertion Route (Billion US$), 2016
Table 9-1: Global - Vascular Access Devices Market by End User (Billion US$), 2016
Table 10-1: Global - Vascular Access Devices Market by Region (Billion US$), 2016
Table 11-1: C. R. Bard, Inc.- Net Sales (Million US$), 2013-2015
Table 11-2: C. R. Bard, Inc. - Product Portfolio for Vascular Access Group
Table 11-3: AngioDynamics, Inc. - Net Sales (Million US$), 2014-2016
Table 11-4: AngioDynamics, Inc. - Product Portfolio for Vascular Access Group
Table 11-5: Smiths Medical - Net Sales (Million US$), 2014-2016
Table 11-6: Smiths Medical - Product Portfolio for Vascular Access Group
Table 11-7: Fresenius Medical Care - Net Sales (Million US$), 2013-2015
Table 11-8: Fresenius Medical Care - Product Portfolio for Vascular Access Group
Table 11-9: Teleflex Incorporated - Net Sales (Million US$), 2013-2015
Table 11-10: Teleflex Incorporated - Product Portfolio for Vascular Access Group
Table 11-11: Medtronic plc - Net Sales (Million US$), 2014-2016
Table 11-12: Medtronic plc - Product Portfolio for Vascular Access Group
Table 11-13: Becton, Dickinson and Company - Net Sales (Million US$), 2013-2015
Table 11-14: Becton, Dickinson and Company - Product Portfolio for Vascular Access Group
Table 11-15: B. Braun Melsungen AG - Net Sales (Million US$), 2013-2015
Table 11-16: B. Braun Melsungen AG - Product Portfolio for Vascular Access Group
Table 11-17: NIPRO Medical Corporation - Net Sales (Million US$), 2014-2016
Table 11-18: NIPRO Medical Corporation - Product Portfolio for Vascular Access Group
Table 11-19: Medical Components, Inc. - Product Portfolio for Vascular Access Group